Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propolis for Hand Foot and Mouth Disease
NCT06455007Phase 3Completed
- Start
- Jan 2019
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms). Primary endpoints: Severity of restlessness, inappetence, and sleeplessness, Duration of complaints up to 10 days and 2 more. Started Jan 2019; status: completed.
Beyond the preview
Go deeper on NCT06455007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06455007.